Some aspects of the protein metabolism in human liver transplant recipients by Groth, CG et al.
Some Aspects of the Protein Metabolism in 
Human Liver Transplant Recipients 
C. G. Groth, N. Kashiwagi, M. Torisu, G. Schroter, A. Gustafsson, J. Corman,S. Iwatsuki, 
T. E. Starzl 
In early experimental and clinical studies, 
the not unexpected finding was reported that 
most of the electrophoretically measurable 
protein fractions declined rapidly after the im-
plantation of a poorly functioning hepatic ho-
mograft. In contrast, these fractions were 
well maintained after provision of a well 
functioning graft. A similar relationship 
between quality of graft function and pro-
,ein levels was found also for the liver-
based clotting factors. The changes in these 
latter factors were very rapid and reflec-
ted changes in consumption as well as 
synthesis [Z]. 
Studies of Complement 
Recently, the plasma proteins of the 
complement system were assayed in five 
recipients of hepatic homografts [3]. All the 
patients were in terminal liver failure due 
to cirrhosis, chronic hepatitis or Wilson's 
disease. 
Following replacement of the patients' 
diseased livers with well functioning homo-
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grafts, total complement activity as well 
as the C4 and C3 component activities, 
rose from distinctly low to normal levels. 
At the same time, the Cs component incre-
ased from low to high normal (Figure 1). 
In contrast, the Cz and C9 components 
remained normal throughout, while C1 
showed variable changes. Good subsequent 
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Fig. 1 Levels of total complement activity 
(CH 50) and of the components C4, C3 and 
CS, before and 7-10 days after orthotopic he-
patic transplantation. Each line represents an 
individual patient. Normal range is indicated 
by a heavy line along the ordinate. 
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graft function was accompanied by normal 
complement levels except in one patient 
who exhibited supernormal values for sev-
eral months. 
Some of the recipients developed postoper-
ative liver function abnormalities that were 
thought to be due to homograft rejection. 
Concomitantly, there were marked de-
creases in total complement activity and in 
the C4 and C3 components (Figure 2). One 
of these patients later developed biliary 
obstruction which required surgical correction. 
At this time there were no changes in the 
complement system. 
Two other patients had temporary liver 
dysfunction at a time when steep rises in 
Australia antigen titers indicated the occur-
rence of serum hepatitis. In one of these 
patients, a transient decrease in complement 
activities was recorded, but in the other, 
the complement remained unaffected. 
Based on the above data, it has been con-
cluded that complement assays might aid 
in the otherwise equivocal diagnosis of re-
jection. In addition, as has been completely 
discussed elsewhere [3], the data are con-
sistent with the hypothesis that the liver 
is a main or possibly even the sole source of 
the C4, C3 and C5 components of the 
complement system. 
Inborn Errors of Protein Metabolism 
In several liver transplant recipients, 
the genetically determined phenotypes of 
the a-globulins haptoglobin and group spe-
cific component have converted to those 
of the donors. This indicated that the hepa-
tic homograft retained its metabolic specifi-
city in a new host and that liverbased in-
born errors of metabolism should be 
correctable by the provision of a new, 
normal liver. 
There have not yet been any successful 
liver transplantations for proven inborn 
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errors of hepatic metabolism. However, two 
teenage boys have undergone liver replace-
ment for Wilson's disease, a disorder that 
has been speculated to be due to some 
fundamental hepatic defect. The course of 
the first patient has been reported earlier 
[1]. Following transplantation, there was a 
marked cupriuresis and biopsy specimens 
have shown no accumulation of copper in 
the graft as had occurred in the native liver. 
The patient is presently alive and well three 
years after transplantation. 
The second patient when first seen by 
us at age 11, had cirrhosis of the liver, 
a very low level of the coppercontaining 
serum protein ceruloplasmin, a high liver 
copper, Kayser-Fleischer rings, and the 
characteristic histopathologic findings in a 
liver biopsy of Wilson's disease. In spite 
of treatment with chelating agents, the 
patient became severely crippled by neuro-
logical symptoms. At the age of 14, he 
underwent orthotopic hepatic transplan-
tation. Except for an early period of graft 
dysfunction, probably caused by serum he-
patitis, liver function has been norma) 
during a follow-up of 15 months (Figure 3). 
After transplantation, serum ceruloplasmin 
and total serum copper rose to norma) 
levels and have remained 50. An initially 
elevated urinary excretion of copper has 
declined toward normal (Figure 3). Biopsy 
specimens of the homograft have shown no 
accumulation of copper. The findings are 
consistent with the hypothesis that the 
~ 
Fig. 2 Changes in the complement system in 
a patient who developed liver dysfunction 3 
weeks after operation presumably due to re-
jection. Note the concomitant marked drop in 
total .complement and several of the compo-
nents. Subsequently, biliary tract obstruction 
was diagnosed without the occurrence of chan-
ges in complement. The patient succumbed 16 
days later; shortly before death complement 
levels again decreased (By permission of Clin. 
Exp. Immuno!.). 
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Fig.3 The course of the second patient treated with orthotopic hepatic transplantation for 
Wilson's disease at the University of Colorado. Note the prompt recovery of serum cerulo-
plasmin after transplantation. 
metabolic defect in Wilson's disease is 
liver-based, although they do not prove it. 
Summary 
The important relationship between he-
patic homograft quality and the mainte-
nance of plasma proteins is reemphasized. 
The results of serum complement assays in 
liver transplant recipients are presented. The 
recovery of the copper-containing protein cer-
uloplasmin after hepatic transplantation for 
Wilson's disease along with a cessation of 
hepatic copper accumulation is described. 
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